Mauricio Ribeiro

12PUBLICATIONS
57CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersTumour immunologySolid tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Nov 11, 2025
Response to Immune Checkpoint Blockade Is Enhanced in the Presence of Hematopoietic TET2 Inactivation.

Vincent Rondeau, Suraj Bansal, Marco M Buttigieg

|Aug 13, 2025
Prognostic and Predictive Value of ctDNA for Metastatic Uveal Melanoma: A Systematic Review and Meta-Analysis.

Mariana Macambira Noronha, Luís Felipe Leite da Silva, Luiz Felipe Costa Almeida

|Aug 11, 2025
Neoadjuvant Immune Checkpoint Inhibitors in CSCC: A Systematic Review and Meta-Analysis.

Valbert Oliveira Costa Filho, Mariana Macambira Noronha, Pedro Robson Costa Passos

|May 15, 2024
Clinical activity of pembrolizumab in refractory MDM2-amplified advanced intimal sarcomas.

Mauricio Fernando Ribeiro, Elizabeth G Demicco, Albiruni Ryan Abdul Razak

|Oct 02, 2023
Clinico-demographic characteristics and outcomes of radiation-induced sarcomas (RIS): a CanSaRCC study.

Mauricio Fernando Ribeiro, Hagit Peretz Soroka, Zainab Bhura

Pageof 2